Clinical Trials - April 30, 2019
Last follow up visit in Scandinavian Biopharma trial
The company has completed a phase IIB randomized, double-blind, placebo-controlled trial in Finnish travellers going to Benin in West Africa. All participants have now been enrolled and the last travellers left Benin in March 2019. The last follow up visit was conducted just before Easter. In total 743 healthy travellers, between the ages of 18 […]
Clinical Trials - April 23, 2019
Scandinavian Biopharma officially starts their development program in Africa
The Permanent Secretary at Ministry of Health Dr Kennedy Malama together with the Swedish Ambassador Henrik Cederin, Dr Izukanji Sikazwe CEO at Centre for Infectious Disease Research in Zambia (CIDRZ) and Dr Godfrey Biemba CEO at National Health Research Authority (NHRA) in Zambia officially announced April 17th the start of Scandinavian Biopharma’s late phase paediatric development […]
In a new job - April 22, 2017
Scandinavian Biopharma recruits new CFO
The Swedish company continues to expand and at the end of February Peter Liss was appointed as Chief Financial Officer (CFO). Peter Liss will be responsible for business development and he has several years of experience as CFO. Most recently he was CEO and CFO at Valneva Sweden and he has also had similar positions […]
Agreement - April 21, 2017
Scandinavian Biopharma in agreement with Flynn Pharma
Scandinavian Biopharma has entered into an agreement with Flynn Pharma for the viper antivenom ViperaTAb. Under the agreement, Scandinavian Biopharma will have exclusive rights to service and make ViperaTAb available for emergency use in the Nordics, Baltic States and Germany. “We are very pleased to strengthen our portfolio with an important antivenom for Northern Europe” […]
In a new job - March 8, 2017
Scandinavia Biopharma is expanding
Scandinavian Biopharma is expanding by hiring a PhD in cell- and molecular biology. Teresa Holmlund has joined the company. She has a PhD in cell and molecular biology and ten years of academic research experience studying molecular mechanisms in mitochondrial disease, cancer and severe congenital neutropenia. “It feels great to be a part of Scandinavian […]
Clinical Trials - February 28, 2017
450 participants enrolled in Scandinavian Biopharma’s study
One and a half year ago a phase I/II randomized, double-blind, placebo-controlled trial was started by Scandinavian Biopharma in Dhaka, Bangladesh, and now, all 450 participants have been enrolled and the last child received the vaccine this February. “This clinical trial is the first important step toward showing that our vaccine can protect children in […]
